What does compounded semaglutide mean?

It means semaglutide prepared by a compounding pharmacy, which mixes or alters ingredients to make a customized product, rather than the finished, FDA-approved products made by Novo Nordisk (Ozempic, Wegovy, Rybelsus). Compounded versions are not FDA-approved.

Is compounded semaglutide the same as Ozempic or Wegovy?

No. Ozempic, Wegovy, and Rybelsus are FDA-approved branded products with a reviewed manufacturing process. Compounded semaglutide is prepared outside that process and is not FDA-approved, even if it contains the same named ingredient.

Why did compounded GLP-1 products become common?

When branded GLP-1s were in shortage, U.S. rules allowed certain compounding to help meet demand. That, combined with high prices and demand, drove a large market for compounded versions. The legal picture shifts as drugs move on and off the FDA shortage list.

What safety concerns has the FDA raised?

The FDA has reported dosing errors (often from people measuring and self-injecting from vials), and has flagged products using semaglutide salt forms that differ from the approved ingredient. Quality, sterility, and accuracy can vary because compounded products are not FDA-reviewed. This is general information, not medical advice.

Is compounded semaglutide legal?

Compounding itself is a regulated activity, but the rules depend on factors like shortage status, the type of pharmacy, and the exact ingredient used. This page explains the concept; it does not give legal or medical guidance on any specific product or source.

Concepts & Terms

What Is Compounded Semaglutide?

Published Jun 29, 2026 · Updated Sep 12, 2026 · 6 minute read

Compounded semaglutide became one of the most talked-about topics in the GLP-1 world, often wrapped in confusion. This page explains what compounding actually is, why compounded GLP-1s appeared, and the cautions regulators have raised, without telling you what to do.

Medical Supervision Required:Peptide Tracker is for private logging, calculations, reminders, inventory records, and education. It is not medical advice, dosing instruction, prescribing guidance, diagnosis, or a substitute for a qualified healthcare professional.

Key Takeaways

Compounding is when a pharmacy prepares a customized medication rather than dispensing a manufacturer's finished product.
Compounded semaglutide is not the same as FDA-approved Ozempic, Wegovy, or Rybelsus, and compounded products are not FDA-approved.
Demand surged during brand shortages, which under U.S. rules can temporarily expand certain compounding.
The FDA has warned about dosing errors and quality risks with compounded GLP-1 products, including non-standard salt forms.
When a drug leaves the FDA shortage list, the rules around compounding it change.
This page is educational and is not medical advice; it does not endorse or condemn any source.

1. What Is Compounding?

Compounding is when a licensed pharmacy prepares a customized medication for a patient, rather than dispensing a manufacturer’s finished, sealed product. It is a long-standing, regulated practice used, for example, to adjust a dose form or remove an allergen.

Compounded semaglutide means semaglutide prepared through that process, as opposed to the FDA-approved branded products: Ozempic, Wegovy, and Rybelsus.

Term	What it means
Compounding	A pharmacy preparing a customized medication.
Compounded semaglutide	Semaglutide made via compounding, not by the brand manufacturer.
FDA-approved product	A finished drug whose manufacturing and labeling the FDA has reviewed.
Shortage list	The FDA’s list of drugs in short supply, which affects compounding rules.

2. Compounded Is Not the Same as Approved

This is the most important distinction. An FDA-approved product like Ozempic has gone through a reviewed manufacturing and quality process. A compounded product, even one labeled “semaglutide,” has not been FDA-approved, and its preparation happens outside that review.

Same named ingredient does not mean same product, same quality controls, or same regulatory status.

3. Why Compounded GLP-1s Appeared

Two forces drove the surge:

Shortages: when branded GLP-1s were in short supply, U.S. rules allowed certain compounding to help meet demand.
Demand and price: intense interest in GLP-1s, combined with cost, created a large market for alternatives.

Crucially, the rules change when a drug comes off the FDA shortage list. Compounding that was permitted during a shortage may no longer be once supply recovers, which is why this area shifts over time.

The dates that matter

Date	What happened
March 2022	FDA adds semaglutide injection to the drug shortage list. Bulk compounding of copies becomes permissible under the shortage exception.
Late 2022 to May 2023	State pharmacy boards, then FDA in a May 2023 statement, warn about compounded products made from semaglutide sodium or acetate, salt forms that are not the approved active ingredient.
December 2024	FDA declares the tirzepatide shortage resolved; compounded tirzepatide loses the exception first.
February 21, 2025	FDA declares the semaglutide injection shortage resolved.
April 22, 2025	End of the enforcement-discretion period for 503A pharmacies compounding semaglutide.
May 22, 2025	End of the enforcement-discretion period for 503B outsourcing facilities.

After those dates, compounding a product that is “essentially a copy” of Wegovy or Ozempic is no longer covered by the shortage exception. Compounding for a documented individual clinical need, such as an allergy to an excipient, remains possible under 503A. The two pharmacy categories differ: 503A pharmacies compound for individual prescriptions under state board oversight; 503B outsourcing facilities compound in bulk under FDA oversight and current good manufacturing practice. Enforcement is FDA’s and the states’, and it has changed more than once; the FDA shortage database shows current status. For the product-level comparison, see Wegovy vs compounded semaglutide.

4. Safety Cautions Regulators Have Raised

The FDA has publicly flagged several concerns with compounded and unapproved GLP-1 products:

Dosing errors: people drawing and self-injecting from vials have made measurement mistakes, sometimes taking far more than intended.
Non-standard ingredients: some products used semaglutide salt forms that differ from the approved active ingredient.
Quality and sterility: because compounded products are not FDA-reviewed, accuracy, sterility, and purity can vary by source.

Dosing errorsMeasuring and self-injecting from vials has led to mistakes, sometimes far more than intended.

Non-standard ingredientsSome products used semaglutide salt forms that differ from the approved active ingredient.

Quality & sterilityNot FDA-reviewed, so accuracy, sterility, and purity can vary by source.

5. Compounded vs Brand vs Investigational

It helps to separate three categories that often get blurred:

Category	Example	FDA-approved?
Branded, approved	Ozempic, Wegovy, Rybelsus	Yes
Compounded	Compounded semaglutide	No
Investigational	Retatrutide, VK2735	No (in trials)

Compounded and investigational products are both outside the approved category, but for different reasons: one is prepared by a pharmacy, the other is still being studied.

6. The Recordkeeping Angle

For anyone keeping personal logs, the key boundary is honesty about what is being recorded. A tracking record can note a product name, source, and dose a person enters, but it cannot verify quality, sterility, legality, or authenticity. See What Is a Peptide? and the inventory section of the tracking guide for how product and source notes are recorded without making quality claims.

Compounded = pharmacy-prepared, not brand-manufactured.
Not FDA-approved, unlike Ozempic, Wegovy, and Rybelsus.
Shortage-driven, with rules that change as supply changes.
Carries cautions the FDA has documented around dosing and quality.

7. Compounded Semaglutide FAQ

What does compounded semaglutide mean?

It means semaglutide prepared by a compounding pharmacy, which mixes or alters ingredients to make a customized product, rather than the finished, FDA-approved products made by Novo Nordisk (Ozempic, Wegovy, Rybelsus). Compounded versions are not FDA-approved.
Is compounded semaglutide the same as Ozempic or Wegovy?

No. Ozempic, Wegovy, and Rybelsus are FDA-approved branded products with a reviewed manufacturing process. Compounded semaglutide is prepared outside that process and is not FDA-approved, even if it contains the same named ingredient.
Why did compounded GLP-1 products become common?

When branded GLP-1s were in shortage, U.S. rules allowed certain compounding to help meet demand. That, combined with high prices and demand, drove a large market for compounded versions. The legal picture shifts as drugs move on and off the FDA shortage list.
What safety concerns has the FDA raised?

The FDA has reported dosing errors (often from people measuring and self-injecting from vials), and has flagged products using semaglutide salt forms that differ from the approved ingredient. Quality, sterility, and accuracy can vary because compounded products are not FDA-reviewed. This is general information, not medical advice.
Is compounded semaglutide legal?

Compounding itself is a regulated activity, but the rules depend on factors like shortage status, the type of pharmacy, and the exact ingredient used. This page explains the concept; it does not give legal or medical guidance on any specific product or source.

8. Sources

References used for this article